October 4, 2017 / 2:57 PM / 2 years ago

Swiss Amicus and Brazil's EMS bid for Serbian drugmaker Galenika

BELGRADE, Oct 4 (Reuters) - Swiss-based drugs company Amicus SRB and Brazilian pharma group EMS SA have both made binding bids for a 93 percent stake in Serbian drugmaker Galenika, Serbia’s Economy Ministry said.

Belgrade wants to sell Galenika as part of an effort to privatise, shut or trim unprofitable state firms under a 1.2 billion euro ($1.4 billion) deal with the International Monetary Fund, but the drugmaker’s debts have so far put off investors.

The Economy Ministry said in a statement on Wednesday that the envelopes with financial offers will be opened after the bids have been verified. (Reporting by Aleksandar Vasovic; Editing by)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below